Education
About Us
Working with TipRanks
Follow Us
Robert Hoffman Insider Profile
4 Followers
Robert Hoffman, Director at Antibe Therapeutics, holds 38.33K shares in Antibe Therapeutics (Ticker: ATBPF). Most recently, Robert Hoffman ― shares of Antibe Therapeutics on ― for an estimated value of ―.
Robert Hoffman Antibe Therapeutics (ATBPF)Director
Antibe Therapeutics (ATBPF)
Director
Not Ranked
Robert Hoffman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Robert Hoffman does not currently own shares as a corporate insider.
A breakdown of Robert Hoffman's holdings
Insider Roles
Robert Hoffman does not currently hold a role as a corporate insider.
Roles that Robert Hoffman holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Robert Hoffman
Robert Hoffman's Trading History
List of latest transactions for each holding click on a transaction to see Robert Hoffman's performance on stock
You May Also Like
Robert Hoffman insider profile FAQ
What is the percentage of profitable transactions made by Robert Hoffman?
The percentage of profitable transactions made by Robert Hoffman is ―.
What is the average return per transaction made by Robert Hoffman?
The average return per transaction made by Robert Hoffman is ―.
What stocks does Robert Hoffman hold?
Robert Hoffman holds: ATBPF stocks.
What was Robert Hoffman’s latest transaction?
Robert Hoffman latest transaction was an Uninformative Buy of ―.
What was Robert Hoffman's most profitable transaction?
Robert Hoffman’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Robert Hoffman's role in Antibe Therapeutics?
Robert Hoffman's role in Antibe Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.